Contract Development

Medix Biochemica - with loads of interdisciplinary excellence, our contract development teams stand poised and ready to tackle the challenges of our customers.  Get in touch today and tell us how our contract development services can help to bring an idea to life and help ease and speed your commercialization process.  

Our broad portfolio of critical raw materials for IVD tests, including high-quality antibodies, antigens, enzymes, biologicals, and molecular biology reagents has helped shape and develop a diverse team full of technical expertise and troubleshooting skills. 

Beyond manufacturing, we exhibit scientific know how and expertise across many specialties that can help to expedite your product to market. Count on us for established expertise, customizable end-to-end services, and dedicated support tailored to your unique requirements.

Familiarize yourself below with a highlight of areas of discipline that you can take advantage of for any contract development needs you have.

Novel mAb discovery

Explore our antibody R&D teams' diverse suite of technologies for novel monoclonal antibody discovery. From mouse hybridoma development to phage display and antibody generation against difficult targets, we provide rigorous functional screening and validation with patient sample material.

Recombinant mAb development

Experience comprehensive recombinant design and engineering services for monoclonal antibody development. Our optimized expression host, CHO cell line, and rigorous functional screening enhance performance for various applications.

DNA polymerase engineering

In our molecular diagnostics division, we employ novel engineering strategies to develop DNA-dependent and RNA-dependent DNA polymerase enzymes. Our unique polymerases, created through directed artificial evolution, offer enhanced characteristics, such as, increased robustness, thermostability, and high fidelity for diverse molecular biology applications.

Explore our track record in DNA polymerase engineering, showcased by our Volcano and HiDi® product families. These innovations facilitate PCR-based detection of RNA from a wide range of sample types without the need for RNA extraction or an independent reverse-transcriptase step (Volcano), and offer precise mismatch discrimination, enabling direct genotyping from sample materials (HiDi®).

In addition, MedixMDx excels in the field of lyophilization, offering collaboration to modify your existing mixture into a format suitable for lyophilization or to create a new mix that meets your specific requirements for the lyophilization process.

MedixMDx also possesses the expertise to produce lyophilized reagents, including lyo-beads and lyo-cakes. Should you be interested in partnering with us for the manufacturing of your mix, we encourage you to contact us.